Due to the overwhelming surge in COVID-19 cases and the strain it has placed on health care capacity in the communities we serve, the Idaho Department of Health and Welfare has activated crisis standards of care statewide. We are open and available to see patients, but you may experience delays at our ERs, hospitals, and clinics. We appreciate your patience. Access more info on COVID testing, vaccination, visitor policy, hospitalization data, and FAQs.

toggle mobile menu Menu
toggle search menu

Site Navigation



National Study for Kids with Nearsightedness

St. Luke's Children's Ophthalmology participates in national study.

Now enrolling children ages 5 to 12 with myopia (nearsightedness) for a national study. 

St. Luke’s Children’s Ophthalmology is part of a national study regarding an eye drop called low-dose atropine that has been shown to slow nearsightedness in children by 50%. The study is funded by the National Institutes of Health and is run by a national group of pediatric eye doctors. 

We're currently enrolling children ages 5 to 12 with nearsightedness. Children will use low dose atropine, or an eye drop with no medicine in it, every day for two years. The study will measure changes in nearsightedness while taking the drop, and after it has been stopped. 

Please call (208) 381-6912 with questions or for more information on enrolling your child.

Principle Investigator

Katherine Lee, MD

Articles & Resources

  • showing 1 of 1